Essential Training on Identification and Assessment of Eating - - PowerPoint PPT Presentation

essential training on identification and assessment of
SMART_READER_LITE
LIVE PREVIEW

Essential Training on Identification and Assessment of Eating - - PowerPoint PPT Presentation

Essential Training on Identification and Assessment of Eating Disorders for the Medical Community The Alliance for Eating Disorders Awareness Every 62 minutes someone dies as a direct result from suffering an eating disorder. Eating Disorders


slide-1
SLIDE 1

The Alliance for Eating Disorders Awareness

Essential Training on Identification and Assessment

  • f Eating Disorders for the

Medical Community

slide-2
SLIDE 2

Every 62 minutes someone dies as a direct result from suffering an eating disorder.

slide-3
SLIDE 3

Eating Disorders Stats…

At least 30 million Americans suffer from an eating disorder in their lifetime

slide-4
SLIDE 4

Eating Disorders are brain-based, biological illnesses with a strong genetic component and psychosocial influences.

slide-5
SLIDE 5

Eating disorders do not

  • discriminate. They can affect

individuals of all ages, genders, ethnicities, socioeconomic backgrounds, and with a variety of body shapes, weights and sizes.

slide-6
SLIDE 6

.

DSM 5: Feeding and Eating Disorders

slide-7
SLIDE 7

Anorexia Nervosa:

(Self-Starvation)

Restriction of energy intake relative to an individual’s requirements, leading to a significantly low body weight in the context

  • f age, sex, developmental trajectory and

health status. Disturbance of body image, an intense fear of gaining weight, lack of recognition of the seriousness of the illness and/or behaviors that interfere with weight gain are also present.

slide-8
SLIDE 8

 9% of American women suffer from anorexia in their

lifetime.

 1 in 5 anorexia deaths is by suicide.  Standardized Mortality Ratio (SMR) for Anorexia Nervosa

is 5.86

 50-80% of the risk for anorexia is genetic.  33-50% of anorexia patients have a comorbid mood

disorder, such as depression.

 About half of anorexia patients have comorbid anxiety

disorders, including obsessive-compulsive disorder and social phobia.

Anorexia Nervosa:

Statistics

slide-9
SLIDE 9

Review of Symptoms: Anorexia

 Sizeable weight change  Dizziness/fainting  Loss/delay menses

(Amenorrhea)

 Orthostatic hypotension  Cold

intolerance/hypothermia

 Brittle nails  Thinning/dull hair  Loss of muscle mass  Constipation  Sleep disturbance  Cognitive impairment  Disturbed body image  Depressive symptoms  Anxiety  Self mutilation

slide-10
SLIDE 10

Physical Findings: Anorexia

 Emaciation  Hypotension  Bradycardia  Syncope  MVP  Edema  Cyanotic

extremities

 Hypothermia  Lanugo hair  Dry skin  Hypercarotenemia  Hyperkeratosis  Anemia  Hypoglycemia  Gastroparesis  Elevated hepatic

enzymes

slide-11
SLIDE 11

Anorexia: The Dangerous Reality

Mortality  Anorexia Nervosa has the highest

mortality rate among all psychiatric disorders.

 The risk of premature death is 6-12

times higher in women with Anorexia Nervosa (AN) as compared to the general population, adjusting for age.

slide-12
SLIDE 12

Bulimia Nervosa

(Binge-Purge)

Binge eating (eating a large amount of food in a relatively short period of time with a concomitant sense of loss of control) with compensatory behavior once a week or more for at least 3 months. Disturbance of body image, an intense fear of gaining weight and lack of recognition of the seriousness of the illness may also be present.

slide-13
SLIDE 13

 5% of American women suffer from bulimia nervosa in

their lifetime.

 Standardized Mortality Ratio (SMR) for Bulimia Nervosa

is 1.93.

 Nearly half of bulimia patients have a comorbid mood

disorder.

 More than half of bulimia patients have comorbid anxiety

disorders.

 1 in 10 bulimia patients have a comorbid substance abuse

disorder, usually alcohol use.

Bulimia Nervosa:

Statistics

slide-14
SLIDE 14

Review of Symptoms: Bulimia

 Average weight w/

weight fluctuation

 Dizziness and fainting  Fatigue  Sialadenosis  Abdominal pain  Bloating/Pyrosis  Bowel paralysis  Sleep disturbance  Disturbed body

image

 Depressive

symptoms

 Anxiety  Feelings of shame

and guilt

 Self injury

slide-15
SLIDE 15

Physical Findings: Bulimia

 Hypertensive  Edema  Hypokalemia  Electrolyte imbalance  Dehydration  Pancreatitis  Extremity weakness  Russell's sign  Sialadenosis  GERD  Dental erosions  Sore throat  Esophagitis  Mallory-Weiss

tears

 Boerhaave

Syndrome

slide-16
SLIDE 16

Binge Eating Disorder (Bingeing)

Binge eating, in the absence of compensatory behavior, once a week for at least 3 months. Binge eating episodes are associated with eating: rapidly, when not hungry, until extreme fullness, and/or associated with depression, shame or guilt.

slide-17
SLIDE 17

 8% of American adults suffer from binge eating disorder in

their lifetime.

 Approximately half of the risk for BED is genetic.  Nearly half of BED patients have a comorbid mood and

anxiety disorder.

 Nearly 1 in 10 BED patients have a comorbid substance

abuse disorder, usually alcohol use.

 Binge eating or loss-of-control eating may be as high as

25% in post-bariatric patients.

 30 percent of higher weight patients attempting to lose

weight in clinical settings meet diagnostic criteria for binge eating disorder (BED) and/or bulimia nervosa (BN).

Binge Eating Disorder:

Statistics

slide-18
SLIDE 18

Binge Eating Disorder : Physical Findings

 Overweight or

  • besity

 Gallbladder

disease

 Increased BP  Increased

cholesterol

 Heart disease  Type II diabetes  Lipid

abnormalities

 Osteoarthritis  Sleep apnea

slide-19
SLIDE 19

Avoidant/Restrictive Food Intake Disorder

Significant weight loss, nutritional deficiency, dependence on nutritional supplement or marked interference with psychosocial functioning due to caloric and/or nutrient restriction, but without weight or shape concerns.

slide-20
SLIDE 20

 ARFID is more common in children and young

adolescents and less common in late adolescence and adulthood.

 ARFID is often associated with psychiatric co-morbidity,

especially with anxious and obsessive compulsive features.

 ARFID is more than just “picky eating”; children do not

grow out of it and often become malnourished because of the limited variety of foods they will eat.

 The true prevalence of ARFID is still being studied, but

preliminary estimates suggest it may affect as many as 5%

  • f children.

 Boys may have a higher risk for ARFID than girls.

ARFID:

Statistics

slide-21
SLIDE 21

Avoidant/Restrictive Food Intake Disorder

Contributing factors to ARFID

 Difficulty digesting certain foods  Avoiding certain colors or textures of food  Eating only very small portions  Having no appetite  Presentation with or without a medical condition  Psychological disorders may be risk factor  Afraid to eat after a frightening episode of choking

  • r vomiting
slide-22
SLIDE 22

Other Specified Feeding or Eating Disorders (OSFED) An ED that does not meet full criteria for one of the above categories, but has specific disordered eating behaviors such as restricting intake, purging and/or binge eating as key features.

slide-23
SLIDE 23

 OSFED affects up to six percent of the population  The mortality rate is estimated to be 5.2 percent for

unspecified eating disorders

 Standardized Mortality Ratio (SMR) for OSFED is 1.92  Nearly half of OSFED patients have a comorbid mood

disorder

 1 in 10 OSFED patients have a comorbid substance abuse

disorder, usually alcohol use

OSFED:

Statistics

slide-24
SLIDE 24

Atypical Anorexia

All criteria for AN are met except, despite significant weight loss the individual’s weight is within or above the normal range.

slide-25
SLIDE 25

Purging Disorder

Recurrent purging behavior to influence weight or shape in the absence of binge eating.

slide-26
SLIDE 26

Chewing and Spitting

A condition in which a person chews up food, usually sweet or high calorie, then spits it out.

slide-27
SLIDE 27

Medical Evaluation

slide-28
SLIDE 28

Evaluation of patients with eating disorders

History:

 Weight/diet

history

 Growth history  Menstrual history

& pattern

 Current & past

medications

 Body image

disturbance

 Nutritional

history

 Compensatory behaviors:

laxative, diuretic, diet pills/stimulants, ipecac use

 Exercise regimen  Suicidal ideations  Psychiatric history

○ including - family history of

disordered eating, addictive disorders, depression, anxiety, etc.  History of Trauma

slide-29
SLIDE 29

Evaluation Continued

 Supine and standing heart rate

and blood pressure

 Respiratory rate  Oral temperature (looking for

hypothermia: body temperature < 96° F/35.6 °C).

 Measurement of height, weight,

and determination of body mass index (BMI)

Vitals:

slide-30
SLIDE 30

Evaluation Continued

Renal Effects

 Renal/Fluids/Electrolytes

 Fluctuations in fluid status with vomiting, laxatives,

diuretic use, fluid restriction, or water loading

 Aldosterone elevation leads to fluid retention  Erratic vasopressin release – excess causes fluid

retention

 Hyponatremia – caused by excessive water intake

○ May present with seizures

 Hypokalemia – caused by purging  Hypomagnesemia

slide-31
SLIDE 31

Evaluation Continued

Gastrointestinal

 Epigastric discomfort  Abdominal bloating  Gastroesophageal reflux  Hematemesis  Hemorrhoids and rectal prolapse  Constipation

slide-32
SLIDE 32

Evaluation Continued

Endocrine

 Genitourinary Effects: Anorexia

 80% of individuals with AN have amenorrhea  Excessive weight loss causes shrinkage of

uterus/ovaries and testicles

○ Usually return to normal once healthy weight is attained

 Menstrual cycles typically resume 1-6 months after

achieving 90% of ideal body weight

 Approximately 17% body fat is needed for menarche

and 22% body fat is needed to maintain menses

slide-33
SLIDE 33

Evaluation Continued

Endocrine

 Genitourinary Effects: Bulimia

 Amenorrhea - Occurs in up to 50% of women

with bulimia nervosa

○ Significant proportion of remaining patients have

irregular periods  Genitourinary Effects: BED

 High levels of androgens cause

○ Abnormal menstrual cycles ○ Block ovulation – difficulty getting pregnant

slide-34
SLIDE 34

Evaluation Continued

Endocrine

 Decreased bone density

 Osteopenia and osteoporosis: chronic

effects of starvation; not readily reversible with weight recovery

 Bone loss influenced by:

○ More than 12 months since onset of

disorder

○ More than 6 months of amenorrhea ○ Body mass index less than 15

slide-35
SLIDE 35

Above, the bone scan of a healthy 25-year-old woman shows normal density. A scan of this 25-year-

  • ld anorexic woman

shows a loss of about

  • ne-third of her bone

mass. X-rays of this 30-year-old anorexic woman reveal the bone density of a 70- year-old.

ANOREXIA NERVOSA: ACCELERATING THE TIMELINE FOR OSTEOPOROSIS

—The New York Times photos

slide-36
SLIDE 36

 Bradycardia/Arrhythmias  Orthostatic hypotension/tachycardia

may reflect dehydration

 Dyspnea  Edema  A starvation cardiomyopathy and heart

failure may occur in severe and chronic AN

Evaluation Continued

slide-37
SLIDE 37

Electrocardiogram

 Typically normal  Signs of hypokalemia  Low voltage changes  Prolonged QTc – Greater than 450  Arrythmias

Evaluation Continued

slide-38
SLIDE 38

Evaluation Continued

Heent:

 Perimyolysis  Oral Trauma  Dental caries  Chipped teeth  Mouth sores  Sialadenosis

slide-39
SLIDE 39

Evaluation Continued

Skin

 Dry skin  Carotenoderma  Hair loss/thinning  Lanugo hair  Russell’s sign  Poor wound healing

Lanugo Hair Carotenoderma

slide-40
SLIDE 40

Evaluation Continued

Labs/Studies

 EKG  CBC w/ diff  Full thyroid panel (T², T³, T, TSH)  Urinalysis; specific gravity, sodium  Bone density scan  Complete metabolic profile  Full chemistry amylase  Serum magnesium/glucose/electrolytes  Amenorrhea evaluation

slide-41
SLIDE 41

Evaluation Continued

 Special Circumstances (e.g. clients <15% IBW)

 Chest x-ray  Complement 3  24 hour creatinine clearance  Uric acid  Brain scan  Echocardiogram  Skin testing for immune functioning  DXA scan (amenorrhea 6+ months)  Estradiol level (or testosterone in males)  ANA, amylase, lipase, LH, FSH, prolactin  UGI+/-SBFT

slide-42
SLIDE 42

Most Common Lab Abnormalities

 Leukopenia  Anemia  Thrombocytopenia   Glucose, Sodium, Potassium, Phosphate,

Magnesium, Chloride

 Hormones

 Low Estradiol (Females)  Low Testosterone (Males)

slide-43
SLIDE 43

Most Common Lab Abnormalities

 “Sick euthyroid”  Low T4, low to normal TSH   Amylase and Lipase   ESR   Creatinine   Calcium   Leptin

slide-44
SLIDE 44

Alert:

Normal labs should not reassure the clinician that the patient is not severely ill.

slide-45
SLIDE 45

Criteria for Acute Medical Stabilization

 Weight more than 25% below IBW/ 16 BMI  Bradycardia < 50 BPM  Temperature < 96 degrees F (< 35.6 C)  Hypotension < 80/50 mm Hg  Orthostasis > 20 BMP  Hypoglycemia  Hypokalemia < 3  Syncope, seizures, cardiac failure, pancreatitis  Renal failure  ECG abnormalities

slide-46
SLIDE 46

Refeeding

slide-47
SLIDE 47
  • Peripheral edema
  • Bloating or discomfort
  • GE Reflux
  • Constipation
  • Rare gastric dilatation
  • Refeeding hepatitis
  • Hypophosphatemia

Refeeding Complaints

slide-48
SLIDE 48

Refeeding Syndrome/ Hypophosphatemia

 Rare, but can be fatal  Anyone with negligible nutrient intake for

more than 5 consecutive days is at risk

 Usually occurs within four days of starting

to refeed

 All electrolytes, especially phosphorus and

magnesium, MUST be checked regularly throughout initial phase of refeeding

slide-49
SLIDE 49

Refeeding Syndrome/ Hypophosphatemia

 Malnourished patient suddenly takes in glucose

(sugar)

 Body reacts by releasing insulin into the blood  Phosphorus suddenly goes from the fluid

between cells to the inside of cells (therefore unavailable)

 Causes weakness, inability to breathe, seizures

and convulsions, confused mental state and even cardiac arrest

slide-50
SLIDE 50

Refeeding Complications

 Wernicke-Korsakoff’s syndrome can be a

complication of refeeding in very low weight anorexia nervosa, especially when comorbid with alcohol abuse.

 Preventative thiamine supplementation is

critically important in these cases.

slide-51
SLIDE 51

Ways to Prevent Refeeding Syndrome

 Be informed about refeeding syndrome and aware

  • f those patients who are potentially at risk.

 Be aware that refeeding syndrome can occur in

patients of any age.

 Use an inpatient medical unit with expertise in

eating disorders to treat and monitor patients who may have, or are at risk for, refeeding syndrome.

 Refeed slowly, adjusting to the age, developmental

stage, and degree of malnourishment.

slide-52
SLIDE 52

Ways to Prevent Refeeding Syndrome

 Monitor fluid replacement to avoid overload

and check serum electrolytes, glucose, magnesium, and phosphorus prior to and closely during refeeding.

 For patients with electrolyte deficits, correct

electrolyte and fluid imbalance alongside

  • feeding. Oral repletion is preferable but IV

supplementation may be necessary.

slide-53
SLIDE 53

Ways to Prevent Refeeding Syndrome

 For those patients who do not present with

electrolyte deficits, carefully monitor on an as electrolyte abnormalities may occur with refeeding.

 Monitor vital signs and cardiac and mental

status of all patients during refeeding.

 Start a multivitamin prior to initiating and

throughout refeeding.

slide-54
SLIDE 54

Screening

slide-55
SLIDE 55
  • 1. Do you make yourself Sick because you feel

uncomfortably full?

  • 2. Do you worry you have lost Control over how much

you eat?

  • 3. Have you recently lost more than One stone (6.35

kg or 14 lb) in a three-month period?

  • 4. Do you believe yourself to be Fat when others say

you are too thin?

  • 5. Would you say Food dominates your life?

*Two or more positive responses on the SCOFF indicates a possible ED and should prompt referral for further evaluation.

The SCOFF

slide-56
SLIDE 56

Screening Questions for BED

 Do you often eat within any 2-hour period what most

people would regard as an unusual amount of food?

 During these binges, do you eat:

Much more rapidly than normal?

Until you feel uncomfortably full?

Large amounts of food when you do not feel physically hungry?

Alone because you are embarrassed by how much you eat?

 Is it upsetting to you that you cannot stop eating or

control what or how much you eat?

 How often do you binge?

slide-57
SLIDE 57

Remember:

Early detection and treatment intervention can have a meaningful impact on symptom severity, quality of life, and mortality rates.

slide-58
SLIDE 58

For more information, please contact:

Alliance for Eating Disorders Awareness (866) 662-1235 www.allianceforeatingdisorders.com Academy for Eating Disorders (703) 234-4079 www.aedweb.org National Eating Disorders Association (800) 931-2237 www.nationaleatingdisorders.org Binge Eating Disorder Association (855)855-2332 www.bedaonline.com

slide-59
SLIDE 59

The Eating Disorders Coalition for Research, Policy & Action thanks Scott J. Crow, MD, and Sonja Swanson, PhD, for their diligence and dedication in researching and compiling these latest statistics on the mortality rate. September 25, 2014

Hudson, J. I., Hiripi, E., Pope, H. G., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biological Psychiatry, 61(3), 348–358.

Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies. Archives of General Psychiatry, 68(7), 724-731.

Trace, S. E., Baker, J. H., Peñas-Lledó, E., & Bulik, C. M. (2013). The genetics of eating disorders. Annual Review of Clinical Psychology, 9, 589-620.

Ulfvebrand, S., Birgegard, A., Norring, C., Hogdahl, L., & von Hausswolff-Juhlin, Y. (2015). Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Research, 230(2), 294-299

Berkman ND, Brownley KA, Peat CM, Lohr KN, Cullen KE, Morgan LC, Bann CM, Wallace IF, Bulik CM. Management and Outcomes of Binge-Eating Disorder. Comparative Effectiveness Review No. 160.

http://www.ncbi.nlm.nih.gov/pubmed/11466589

ARFID: Some new twists and some old themes. Ovidio Bermudez, MD, FAAP, FSAHM, FAED, F.iaedp, CEDS. (2016)

Norris, M. L., Spettigue, W., & Katzman, D. K. (2016). Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth. Neuropsychiatric Disease and Treatment, 12, 213-218.

Canadian Pediatric Surveillance Program

Garber AK, Sawyer SM, Golden NH, Guarda AS, Katzman DK, Kohn MR, Le Grange D, Madden S, Whitelaw M, Redgrave

  • GW. (2016). A systematic review of approaches to refeeding in patients with anorexia nervosa. International Journal of Eating
  • Disorders. 49(3), 293-310.

Mond JM, Myers TC, Crosby RD, Hay PJ, Rodgers B, Morgan JF, Lacey JH, Mitchell JE. (2008). Screening for eating disorders in primary care: EDE-Q versus SCOFF. Behaviour Research and Therapy. 46, 612–22.

Sachs K, Andersen D, Sommer J, Winkelman A, Mehler PS. (2015). Avoiding Medical Complications During the Refeeding of Patients With Anorexia Nervosa. Eating Disorders. 23(5), 411-421.

The Society for Adolescent Health and Medicine. (2015). Position Paper of the Society for Adolescent Health and Medicine: Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults. Journal of Adolescent Health. 56(1), 121–125.

The Society for Adolescent Health and Medicine. (2014). Refeeding Hypophosphatemia in Hospitalized Adolescents With Anorexia Nervosa: A Position Statement of the Society for Adolescent Health and Medicine. Journal of Adolescent Health. 55(3), 455-457.